{{Drugbox
| verifiedrevid = 461769300
| IUPAC_name = 1-cyclohexylaminopropan-2-yl benzoate
| image = Hexylcaine.PNG
<!--Clinical data-->
| tradename =  
| pregnancy_category =  
| legal_status =  
| routes_of_administration =
<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life = <10 minutes
<!--Identifiers-->
| IUPHAR_ligand = 7196
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 532-77-4
| ATC_prefix = none
| ATC_suffix =  
| ATC_supplemental =  
| PubChem = 10770
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = DB00473
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 10315
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 511IU0826Z
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = C14172
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 1197
<!--Chemical data-->
| C=16 | H=23 | N=1 | O=2
| molecular_weight = 261.359 g/mol
| smiles = O=C(OC(CNC1CCCCC1)C)c2ccccc2
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C16H23NO2/c1-13(12-17-15-10-6-3-7-11-15)19-16(18)14-8-4-2-5-9-14/h2,4-5,8-9,13,15,17H,3,6-7,10-12H2,1H3
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = DKLKMKYDWHYZTD-UHFFFAOYSA-N
}}
'''Hexylcaine hydrochloride''', also called '''cyclaine''' ([[Merck & Co.|Merck]]) or '''osmocaine''', is a short-acting [[local anesthetic]].  It acts by inhibiting [[sodium channel]] conduction.  Overdose can lead to [[headache]], [[tinnitus]], [[paresthesia|numbness and tingling]] around the mouth and tongue, [[convulsion]]s, [[respiratory arrest|inability to breathe]], and decreased heart function.


==References==
{{Reflist}}
{{Local anesthetics}}

[[Category:Local anesthetics]]
[[Category:Benzoates]]


{{nervous-system-drug-stub}}